Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets
- PMID: 12603598
- PMCID: PMC1782896
- DOI: 10.1046/j.1365-2567.2003.01585.x
Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets
Abstract
Cyclosporin A (CsA) is a potent immuno-suppressant and is approved for the treatment of various disease conditions. The molecular biological mechanism of CsA has been investigated intensively in T cells and has been shown to involve the intracellular calcineurin pathway. Recently, it was reported that CsA has capacities to affect not only T cells but also antigen-presenting cells such as B cells and dendritic cells (DCs). DCs are a master regulator of immune responses that have an integral capacity to prime naive T cells. In the present study, we investigated the biological effects of CsA on human peripheral blood DC subsets: CD11c+ myeloid and CD11c- lymphoid subsets. CsA inhibited the up-regulation of co-stimulatory molecules induced with or without microbial stimuli and CD40L on both CD11c+ and CD11c- subsets. In addition, CsA negatively regulated the endocytic activity of CD11c+ DC during the immature state. CsA inhibited the interleukin-12 (IL-12) production, but augmented the IL-10 production from the LPS-stimulated CD11c+ subset, whereas CsA reduced the interferon-alpha (IFN-alpha) production from the CD11c- subset infected with Sendai virus (SV). Both the LPS-stimulated CD11c+ subset and SV-infected CD11c- subset preferentially induced the development of IFN-gamma-producing T helper-type 1 (Th1) cells. Pretreatment of these DC subsets with CsA inhibited the Th1 skewing. These findings suggested a DC-mediated mechanism of immunosuppression by CsA.
Figures






Similar articles
-
Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes.Mol Immunol. 2005 Aug;42(12):1531-40. doi: 10.1016/j.molimm.2005.01.006. Epub 2005 Mar 29. Mol Immunol. 2005. PMID: 15950746
-
Differential regulation of human blood dendritic cell subsets by IFNs.J Immunol. 2001 Mar 1;166(5):2961-9. doi: 10.4049/jimmunol.166.5.2961. J Immunol. 2001. PMID: 11207245
-
CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.J Immunol. 2004 Aug 1;173(3):1647-57. doi: 10.4049/jimmunol.173.3.1647. J Immunol. 2004. PMID: 15265893
-
Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand.Blood. 2003 Oct 1;102(7):2513-21. doi: 10.1182/blood-2002-09-2929. Epub 2003 Jun 26. Blood. 2003. PMID: 12829599
-
Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.J Investig Med. 2001 Sep;49(5):442-9. doi: 10.2310/6650.2001.33789. J Investig Med. 2001. PMID: 11523700
Cited by
-
Cyclosporine A, in Contrast to Rapamycin, Affects the Ability of Dendritic Cells to Induce Immune Tolerance Mechanisms.Arch Immunol Ther Exp (Warsz). 2021 Oct 10;69(1):27. doi: 10.1007/s00005-021-00632-7. Arch Immunol Ther Exp (Warsz). 2021. PMID: 34632525 Free PMC article.
-
Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model.Hum Vaccin Immunother. 2020;16(2):240-250. doi: 10.1080/21645515.2019.1616504. Epub 2019 Oct 23. Hum Vaccin Immunother. 2020. PMID: 31070990 Free PMC article.
-
Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.Exp Hematol. 2009 Jan;37(1):143-50. doi: 10.1016/j.exphem.2008.09.011. Exp Hematol. 2009. PMID: 19100524 Free PMC article.
-
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation.Diagnostics (Basel). 2021 Feb 15;11(2):312. doi: 10.3390/diagnostics11020312. Diagnostics (Basel). 2021. PMID: 33671952 Free PMC article.
-
Neuroprotection by immunomodulatory agents in animal models of Parkinson's disease.Neural Regen Res. 2018 Sep;13(9):1493-1506. doi: 10.4103/1673-5374.237108. Neural Regen Res. 2018. PMID: 30127102 Free PMC article. Review.
References
-
- First International Congress on Cyclosporine. Transplant Proc; 16–19 May 1983; Houston, Texas. 1983. pp. 2207–3187. - PubMed
-
- Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 1992;339:324–8. - PubMed
-
- Sketris I, Yatscoff R, Keown P, Canafax DM, First MR, Holt DW, Schroeder TJ, Wright M. Optimizing the use of cyclosporine in renal transplantation. Clin Biochem. 1995;28:195–211. - PubMed
-
- Tugwell P, Bombardier C, Gent M, et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet. 1990;335:1051–5. - PubMed
-
- Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT. Morbidity of cytomegalovirus infection in recipients of heart or heart–lung transplants who received cyclosporine. J Infect Dis. 1985;152:1182–91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials